hnthrowawayacct
hnthrowawayacct on Hacker News
Re:Anthropic's IPO prospectus shows AI vision, surging costs
on Tuesday September 29, 2026 @01:12PM (#49896694)
Seems like it might leave behind underutilized data centers full of subsidized compute seeking paying tenants.
Re:Show HN: iPhone app takes simultaneous images from 2 lenses, fuses ...
on Tuesday August 11, 2026 @01:20PM (#49261467)
very cool app, a few questions: why does the color "temp" of the image change between traditional iphone photography vs your app? it appears to both warm and cool the images. Also why is the contrast decreased, specifically in the library/book store example?
Re:ICE will release body cam video only when seen in the agency's 'bes...
on Friday August 07, 2026 @02:53PM (#49214790)
US midterms are coming up in November, politics are being thrust onto every corner of the internet at the moment.
Re:Use of Bayesian Methodology in Clinical Trials of Drug and Biologic...
on Thursday January 15, 2026 @11:14PM (#46642939)
Horrific stuff seeing the level of expertise leaving the building at FDA. Some of the program managers I’ve dealt with in the past have taken the payout with their roles left vacant. Just absolutely abhorrent levels of leadership, the 30 day response timeframes for submissions is starting to produce some sloppy work on their side.
Re:Use of Bayesian Methodology in Clinical Trials of Drug and Biologic...
on Thursday January 15, 2026 @11:08PM (#46642904)
I’m currently arguing a statistical plan for a neurostim phase two clinical trial IDE submission with the FDA. We got some borderline reckless comments back that are massively out of line with correspondence on previous pivotal submissions. It’s starting to look like some of the reviewers are taking on work outside the scope of their expertise. Really disappointing to see, especially with the new more streamlined MDR reqs coming out of the EU.
Re:Use of Bayesian Methodology in Clinical Trials of Drug and Biologic...
on Thursday January 15, 2026 @06:00PM (#46640648)
It's an FDA guidance doc so you can expect to see this affecting new filings or supplemental filings for upcoming FDA submissions and clinical trial designs. This is good news, statistical plans are always a point of contention during trial design and the submission process. This guidance lays a line in the sand and will remove some of the reviewer-to-reviewer variance present in the current FDA staff.
Re:US Tech Market Treemap
on Friday November 14, 2025 @01:26PM (#45930019)
why is hims and hers listed as a tech company?
Re:Optical diffraction patterns made with a MOPA laser engraving machi...
on Monday October 20, 2025 @12:59PM (#45646227)
This guy always has an unreal amount of engineering lift for hobby videos. A treat to watch every time.
Re:Neuralink 'Participant 1' Noland Arbaugh says his whole life has ch...
on Wednesday August 27, 2025 @10:19AM (#45040093)
One of the biggest unsolved issues with BCI and neural implants is the immune response to implanted electrodes. The tissue buildup and fluid that encapsulates the probe or stimulator drastically increases the impedance of the device and causes all sorts of hard to solve problems for longevity of the implant and whatever therapy or recording it's trying to accomplish.
Re:Russia employing sophisticated DeepFakes to influence German Elections
on Thursday February 13, 2025 @12:02PM (#43038248)
Re:the engineerguy: The Engineering of Duct Tape [video]
on Tuesday May 21, 2024 @12:42PM (#40430745)
Is gaffer's tape the top pick or is there another, higher tier of tape?